• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
APTO

APTO

Aptose Biosciences Inc.

NASDAQHealthcareBiotechnologyCA

USD1.71

+1.71 (+100.00%)

Company Profile

CEO

William G. Rice

IPO Date

1992-03-16

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

CA

Market Metrics

Open

$1.71

Prev. Close

$1.71

Day Low

$1.71

Day High

$1.71

52W Low

$1.10

52W High

$43.19

Market Cap

$0.00B

Volume

0.65M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

19.7%

Avg Negative

12.3%

Avg Neutral

68.0%

News Feed

Aptose to Present at September Investor Conferences

GlobeNewsWire·8/30/2021·↑ positive

Aptose Biosciences (APTO) Loses 19.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks Investment Research·8/6/2021·↓ negative

Aptose: High Risk, High Reward. Watch Its Phase I Studies

Seeking Alpha·8/5/2021·↑ positive

Aptose Biosciences Inc. (APTO) CEO William Rice on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/3/2021·↓ negative

Aptose Reports Results for the Second Quarter 2021

GlobeNewsWire·8/3/2021·↑ positive

Aptose to Report Second Quarter 2021 Financial Results and Hold Conference Call on Tuesday, August 3, 2021

GlobeNewsWire·7/20/2021·↓ negative

Aptose Biosciences Stock Tumbles As Luxeptinib Fails To Impress At EHA2021 Virtual Congress

Benzinga·6/11/2021·↑ positive

Aptose Presents Highlights from EHA During Corporate Update Event

GlobeNewsWire·6/11/2021·↑ positive

Aptose: Cancer Trial Catalyst Ahead At EHA21

Seeking Alpha·6/10/2021·↑ positive

Aptose to Hold Corporate Update Friday, June 11th

GlobeNewsWire·5/27/2021·↑ positive